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INTRODUCTION
Mycobacterium tuberculosis (Mtb) infection is characterized by the formation of compact and multicellular host structures called granulomas. These aggregates form in response to the phagocytosis of Mtb by alveolar macrophages and other cells which triggers pro-inflammatory signals (Flynn et al. 2011) . Granulomas are mainly comprised of mature and differentiated macrophages surrounded by lymphocytes. They function both as a niche for the bacteria to establish a robust infection and as a host protective structure that restrains bacterial growth and spread (Ramakrishnan 2012) . Proper functioning of granulomas determines whether the infection will stay contained or progress to active disease (Flynn et al. 2015) . Much of research effort has focused on understanding granuloma formation and maintenance in an attempt to unravel the mechanisms of disease progression and subsequently develop methods to control tuberculosis (TB).
It has now become evident that the first steps of granuloma formation are critical for the eventual outcome of the infection (Cadena, Flynn and Fortune 2016) . Studies in animal models have implicated interactions of mycobacteria with early innate mechanisms in newly emerging caseous granulomas (Turner, Basaraba and Orme 2003; Lin et al. 2006) . Work in zebrafish infected with Mycobacterium marinum has shown how bacteria exploit macrophage death during the early innate immune stages of granuloma formation to proliferate and disseminate throughout the host (Davis and Ramakrishnan 2009) . Srivastava et al. demonstrated that Mtb infects diverse myeloid cell subsets in the lung during the early phase of infection in a mouse model (Srivastava, Ernst and Desvignes 2014) . It was then proposed that, since individual cell subsets exhibit distinct functional properties, early cell recruitment skewed toward one subset or another will likely dictate granuloma response to Mtb. Local differences in forming granulomas would ultimately influence the overall outcome of infection.
Immunological events following Mtb infection include an early recruitment of monocytes from neighboring blood vessels to the site of infection in response to inflammatory signals (Flynn et al. 2011; Mattila et al. 2013) . These monocytes contribute to the cellular matrix of the early granuloma (Russell et al. 2009 ). They are a source of myeloid DCs, alveolar macrophages and recruited interstitial macrophages. Importantly, Srivastava et al. showed that a small but constant percentage of monocytes in the mouse lung were infected with Mtb throughout the infection (Srivastava, Ernst and Desvignes 2014 et al. 2010) . Alterations in monocyte subsets and expansion of CD16 + monocytes have been described in patients with TB and correlated with disease severity (Sanchez et al. 2006; Balboa et al. 2011) . In the context of Mtb infection, CD16 + monocytes have been shown to be dramatically impaired in their capacity to differentiate into functional DCs or macrophages; to produce more TNF-α and less IL-10; to exhibit lower phagocytic capacity; and to be more prone to cell death in response to infection (Castano, Garcia and Rojas 2011; Balboa et al. 2013 (Lastrucci et al. 2015) . A study in a transfer mouse model showed that CD16 − monocytes displayed a higher lung migration index, promoted leukocyte recruitment to the lungs and decreased lung bacterial load in comparison with CD16 + monocytes upon infection with Mtb . Balboa et al. proposed that monocyte subsets are committed to precise functions in the infected lung and therefore contribute differentially to the early immune response against Mtb (Balboa et al. 2013; Balboa et al. 2015) .
Although the influx of monocytes into the lungs appears to be a major component of the early immune events following infection with Mtb, the contribution of each monocyte subset in the granulomatous response remains poorly explored. A first step towards understanding how infection of different monocyte subsets would alter granuloma function is to define which monocyte subset is the target of mycobacterial infection. The non-pathogenic Mycobacterium bovis BCG strain has proven to be a useful model to study the granulomatous response to mycobacterial infection (Seitzer and Gerdes 2003; Puissegur et al. 2004; Rhoades et al. 2005) . Here, we have exploited the ability of M. bovis BCG to infect human monocytes and produce granulomas in vitro to develop a new assay to address Mycobacterium infectivity of monocyte subsets. We propose a flow-cytometrybased analysis to define monocyte populations infected with M. bovis BCG in an in vitro infection model of peripheral blood mononuclear cells (PBMCs) leading to granuloma formation. This assay also enabled us to assess infection rates, cell death rates and overall monocyte subset composition upon infection prior to granuloma formation.
MATERIALS AND METHODS

Ethics
Human peripheral blood was obtained from healthy donors at the University of California, Berkeley. The study was approved by the Institutional Review Board of the University of California, Berkeley. All blood donors provided written informed consent. Five of the blood donors had previously been vaccinated with BCG but all were negative by the PPD skin test.
Bacterial strains and growth conditions
Mycobacterium bovis BCG Pasteur was obtained from the ATCC. Mycobacterium bovis BCG Pasteur constitutively expressing the green fluorescent protein (GFP) was a gift from the laboratory of Dr. Sarah Stanley. Mycobacterium bovis BCG transformed with the reporter plasmid pCHARGE3 (Addgene plasmid # 24 658) and expressing Turbo-635 was kindly provided by Michael Schump (Carroll et al. 2010) . Bacteria were grown at 37
• C in Middlebrook 7H9 medium (Difco) supplemented with 10% ADC (0.5 g/l BSA, 2g/l dextrose and 0.08 g/l NaCl), 0.05% Tween-80 and 0.5% glycerol.
Isolation of PBMCs
Whole blood was collected in Vacutainer tubes with sodium heparin anticoagulant reagent (BD Biosciences) and processed immediately for PBMC isolation. Blood was diluted 1:1 with PBS, layered onto Ficoll-Paque PREMIUM (GE Healthcare) and processed according to manufacturer's instructions. Isolated PBMCs were frozen at 10 7 cells per ml in fetal bovine serum (FBS, Mediatech, VA) with 10% dimethyl sulfoxide. When needed, PBMCs were thawed, washed and resuspended in complete RPMI (cRPMI) containing 10% FBS and 2 mM L-glutamine. Cells rested for 1 hr at 37
• C with 5% CO 2 before we proceeded with cell count (trypan blue dye exclusion method) and infection.
Infection
Bacterial cultures with an OD 600 of 0.5-0.6 were spun down at 50 × g for 5 min to remove clumps. Supernatant was centrifuged at 1900 × g for 5 min. Bacterial pellets were washed once and resuspended in phosphate-buffered saline (PBS). Required strain of M. bovis BCG was added to PBMCs at a multiplicity of infection (MOI) of 1:100 in cRPMI. Infected cells and uninfected cells were kept at 37
• C in 5% CO 2 incubator. Following 2-and 6-hr incubations, PBMCs were seeded to produce granulomas or immunostained for flow cytometry.
Formation of in vitro granulomas
Following infection with M. bovis BCG expressing Turbo-635, PBMCs were washed with PBS and seeded onto an extracellular matrix (ECM), pH 7.0, containing 0.75 mg/ml type I bovine collagen (Purecol, Advanced Biomatrix) and 1.25μg/ml bovine fibronectin (Sigma) in cRPMI (Kapoor et al. 2013; Parasa et al. 2014) . Before adding cells, 250 μl ECM were pipetted onto each 12-well Costar Transwell insert (Corning). Plates were incubated for 2 hr at 37
• C to solidify ECM and 6 × 10 5 PBMCs were seeded per insert. cRPMI was added in the outer well and seeded PBMCs were incubated at 37
• C in 5% CO 2 incubator. After 24 hr, medium in lower chamber was changed and 300 μl medium added to insert.
Granuloma staining for confocal imaging
PBMCs in Transwells were fixed overnight at 4
• C in 4% formaldehyde. Following two PBS washes, membranes of inserts were cut out. Cells were then stained for actin for 2 hr in 2X CytoPainter Phalloidin-iFluor 488 reagent (ABCAM); or for lipid bodies for 1 hr in 1X Bodipy 493/503 (Invitrogen); or incubated with α-CD3 (T-cell marker) polyclonal rabbit and α-CD68 (KP1; macrophage marker) mouse monoclonal anti-human antibodies (Fisher) overnight followed by 1-hr incubation with secondary antibodies goat antirabbit IgG, Alexa Fluor 488 and goat anti-mouse IgG1, Alexa Fluor 633, respectively. Secondary-antibody-only controls were run in parallel. After two PBS washes, membranes were mounted onto microscope slides in Prolong Gold antifade reagent with DAPI (Molecular Probes).
Granuloma counting and measurement
Following staining with phalloidin, each membrane was scanned on the widefield DeltaVision Elite microscope (GE Healthcare) under GFP filter. Images were then analyzed on Bitplane Imaris (Oxford Instruments) with the Surfaces function.
To count and measure aggregates with an area of at least 6000 μm 2 , the following parameters were used: source channel at 523 nm; Smooth option selected with Surface Detail at 10 μm; Background Subtraction with Sphere Diameter at 100 μm; threshold was adjusted manually to cover individual granulomas; surfaces were filtered to include areas larger than 1200 voxels. The Surfaces function rendered 3-D objects with two sides and thickness of 1 voxel, so the 2-D cross-sectional area is the total surface area divided by two.
Confocal imaging
Cells were imaged on a Zeiss LSM710 confocal microscope. DAPI fluorescence was excited with a 405-430 nm diode laser line and collected with a 410-490 nm emission filter. For Phalloidin-iFluor 488 and Alexa Fluor 488, we used the 488 nm line of an Argon laser and fluorescence emission was collected between 500 and 550 nm. For Turbo-635, we used the 594 nm line of a HeliumNeon laser and emission between 600 and 650 nm was collected.
For Alexa Fluor 633, we used the 633 nm line of a Helium-Neon laser and emission above 650 nm was collected. Images were acquired on a Zeiss LSM710 confocal microscope and processed on ImageJ (Schindelin et al. 2012) . 
Immunolabeling for flow cytometry
Statistical analysis
Scatter plots were generated with the ggplot2 package in R (Team 2013) . We performed Wilcoxon ranked-sign tests with the R function Wilcox test to compare the composition of monocyte population in 2-vs 6-hr infections and in uninfected vs infected PBMCs.
RESULTS
Formation of in vitro granulomas
As we wanted to analyze the infectivity of monocytes in the context of granuloma formation, we first had to establish which conditions of infection led to the formation of granulomas in vitro. We infected PBMCs with M. bovis BCG expressing the reporter Turbo-635 at MOI of 1:1000, 1:100 or 1:10 for 2 or 6 hr. To assess the overall infection profile for each condition and donor, we scanned the whole membranes bearing the infected cells in collagen matrix for actin staining and counted and measured granulomas. Parameters on Imaris were set to remove the numerous aggregates composed of few cells and we then quantified the size and numbers of aggregates above 6000 μm 2 . We found that an MOI of 1:100 produced the largest and most stable granuloma-like structures. Fig. 1A shows the number and size of the aggregates at day 11, when aggregates are the largest and most numerous before the structures start breaking down. Mean area was between 6000 and 10 000 μm 2 for all donors except for donor 3010 after 2-hr infection when large structures above 20 000 μm 2 were formed. We observed variation between donors in the number of granulomas produced, ranging from 1 to 19 for 2-hr incubations while 6-hr incubations yielded 15 to 35 aggregates. Six-hr infection of PBMCs from donors 101 and 3010 yielded the most granulomas with 35 aggregates of at least 6000 μm 2 . When looking at the effect of a longer incubation time of PBMCs with M. bovis BCG, we did not see larger aggregates formed after 6-hr infection but for all donors, we did find an increase in the number of granulomas of 1.3-to 16.0-fold. Donors 9 and 101 exhibited the highest increase in aggregates produced.
No cellular aggregation was observed in uninfected cell cultures throughout the course of the study. PBMC infection at an MOI of 1:1000 resulted in the aggregation of few cells while infection at an MOI of 1:10 resulted in cell death (as assessed by the weakness of phalloidin-iFluor 488 signal), no cell aggregation and extracellular clumps of M. bovis BCG (data not shown).
The structure of the aggregates formed was then analyzed by confocal microscopy. Fig. 1B illustrates the typical progression of granuloma formation following 6-hr incubation of PBMCs with M. bovis BCG at an MOI of 1:100 over 3 weeks post-infection. Imaging of granulomas at day 3 revealed nascent aggregates with few intracellular bacteria. At days 8 and 11, larger, compact and multilayered structures with a restricted number of intracellular bacteria were observed. At day 15, aggregates progressed into looser aggregates composed of more highly infected cells. At a later stage, at day 21 post-infection, most granulomas had fallen apart and clumps of extracellular bacteria could be seen throughout the collagen matrix. Panel 1C illustrates the granuloma hallmarks we observed in our model. Multinucleated giant cells (MGCs) were found within aggregates composed of few cells at eight or more days post infection in each infection. Some MGCs contained a large number of nuclei tightly organized in a ring close to the membrane, with intracellular bacteria visible as shown in image 1. We also observed smaller/nascent MGCs with two to three nuclei as depicted in image 2. Immunostaining for CD68, a macrophage-specific marker, was performed and confirmed that the MGC belonged to the monocyte/macrophage lineage (data not shown). Vacuolar distribution of bacteria residing within phalloidin-stained vesicles was visible in some cells (image 3). Immunostaining of aggregates showed the recruitment of cells positive for CD68, macrophages and cells with little cytoplasm positive for CD3, a T cell marker (image 4). Finally, we confirmed the presence of foamy macrophages in larger structures with cells positively stained for lipid bodies (image 5). We also found heavily infected cells with a high number of lipid bodies as shown in image 6.
We decided to pursue our in vitro infection assays with an MOI of 1:100 for 6 hr as they produced at least 15 stable aggregates with an area above 6000 μm 2 and with the major characteristics of granulomas associated with Mycobacterium infection. As increasing the time of infection led to more granulomas produced, we also conducted 2-hr infections to investigate changes in monocyte infection over time.
M. bovis BCG infectivity of monocyte subsets
To determine which monocyte subset(s) become(s) infected with M. bovis BCG, we isolated PBMCs from six healthy blood donors and infected them with M. bovis BCG expressing the reporter protein GFP for 2 and 6 hr. Human monocyte subsets can be distinguished by flow cytometry based on the expression of the cell surface markers CD14 and CD16 (Ziegler-Heitbrock et al. 2010) . Fig. 2 illustrates the gating strategy used to discriminate infected monocytes and to identify the subsets they belong to. bovis BCG expressing GFP were identified based on the FMO control PBMCs infected with wild-type M. bovis BCG (Fig. 2H) . Fig. 3 represents the subset composition of infected monocytes. We found that infection rates among monocytes reached 0.5% to 0.8% after 2 hr and 2.6% to 5.0% after 6 hr, with a 3.3 to 7.0 fold increase in the percentage of monocyte infected over time. hr. Interestingly, we also observed that, while CD16 + cells composed at least 30% of the monocyte population, this cell subset represented only 2.9% and 3.5% of infected monocytes in donors #201 and #600, respectively, after 2 hr of infection (Fig. 3) .
Monocyte death following infection with M. bovis BCG
As CD16 + cells have been reported to be more prone to cell death than CD14 + monocytes upon infection, we looked at cell death in monocyte populations for each donor following 2-and 6-hr incubations in the presence and absence of M. bovis BCG (Table 1) (Castano, Garcia and Rojas 2011) . First, we found high variability among donors when comparing monocyte death in infected and uninfected PBMCs: some subjects exhibited decreases in monocyte death while others showed sharp increases upon infection. Similar results were found for overall cell death rates in PBMCs (data not shown). 
Composition of monocyte population upon infection with M. bovis BCG and over incubation time
As CD14 + CD16 + monocytes have been shown to expand upon in vitro viral infections (Kwissa et al. 2014; Michlmayr et al. 2017) , we compared the composition of the monocyte population in uninfected PBMCs (data not shown) vs infected PBMCs for each donor (Fig. 3) . We grouped samples in two sets, each including 2-and 6-hr incubations: 12 uninfected PBMC samples vs 12 infected PBMC samples. We ran a Wilcoxon signed-rank test to compare the two sets and found that infection did not significantly affect the proportion of monocyte subsets: CD16 + , V = 55, P-value = 0.2094; CD14 + , V = 21, P-value = 0.2858; CD14 + CD16 + , V = 21.5, P-value = 0.1696. We also looked at changes over time by comparing monocyte populations at 2-hr and 6-hr incubations. All donors saw a decrease in the percentage of CD16 + monocytes and an increase in the percentage of CD14 + monocytes between 2 and 6 hr incubations (except for uninfected PBMCs for donor #9). We found that during incubation time the CD14 + CD16 + population expanded in all donors. A Wilcoxon signed-rank test indicated that the composition of monocyte population was significantly different at 2 and 6 hr with the following values: CD16 + , V = 76, P-value = 0.004; CD14 + , V = 8, P-value = 0.015; CD14 + CD16 + , V = 0, P-value = 0.002.
DISCUSSION
Given the critical role of monocytes in the early granuloma response to Mtb infection, it is important to understand how monocyte subsets can differentially support the formation of granuloma structures. Here, we described a flow-cytometry- Mtb infection. It highly expresses the chemokine receptor CCR2 (Wong et al. 2011) . Work in mouse chimera models to study first stages of infection showed that bacteria were likely transported from the lungs or granulomas to lung-draining lymph nodes by monocytes expressing CCR2 (Samstein et al. 2013; Orme, Robinson and Cooper 2015) . A study in a transfer mouse model has also implicated CD14 + monocytes in early leukocyte recruitment to the lungs and in decreased lung bacterial load upon infection with Mtb . As increased cell death in sorted CD16 + monocytes upon infection had been described, we compared subset distribution in dead-and live-infected monocytes for each donor and found that they were similar (Castano, Garcia and Rojas 2011 (Ellery et al. 2007; Wong et al. 2011; Kwissa et al. 2014 , Michlmayr et al. 2017 ; (ii) we did not perform independent infections for each subset but looked at Mycobacterium infectivity in a context where all monocyte subpopulations 'compete' for infection. Infecting sorted monocytes vs all PBMCs or infecting independently each monocyte subset represents a different assessment of infectivity; (iii) we were able to look at very early events in infection; (iv) we ran infection assays under conditions yielding stable granulomas in vitro. Other groups have looked at later time points in infection, assessing the permissivity to Mtb replication of monocyte subsets purified with immunomagnetic beads (Dhiman et al. 2011; Balboa et al. 2015 (Michlmayr et al. 2017) . In our study, M. bovis BCG preferentially infected CD14 + monocytes and CD14 + CD16 + monocytes represented less than 1% of infected monocytes. Infectivity of monocyte subsets appears to vary between infectious agents. Our results also showed that monocyte subset distribution remained unchanged upon infection in each donor but revealed that CD14 + CD16 + population expanded over time, regardless of infection. This finding highlights the importance of controlling for incubation times when studying changes in monocyte subsets. Our study was conducted with M. bovis BCG, a vaccine strain has served as a model organism to study granuloma formation but may not reflect what happens with the pathogenic strain Mtb. It also relied on the infection of PBMCs, which differs from infectious events that occur in lungs, where infection of alveolar macrophages leads to the recruitment of monocytes, neutrophils and lymphocytes, resulting in the formation of a granuloma. The distribution of monocyte subsets in the lungs will also differ from that in the peripheral blood and will depend on the level of pulmonary inflammation and on the migration capacity of each monocyte subset. Regardless, when seeding PBMCs infected with M. bovis BCG, stable granulomas formed and we observed characteristics of granuloma structures, including intracellular bacteria, macrophage differentiation into MGCs, recruitment of lymphocytes and lipid bodies in macrophages. Thus, the study shows that granuloma formation can be initiated with the infection of a subset of monocyte population. We also found that extending the time of infection increased the percentage of monocytes infected along with the number of granulomas produced. This suggests a role for early recruited monocytes in the formation of granulomas and therefore in the outcome of mycobacterial infection. Infection of monocytes may also be relevant in the context of disseminated mycobacterial infection.
As studying early events in mycobacterial infection in humans is challenging, many research groups rely on the use of in vitro model systems to investigate the human context of Mycobacterial infection (Fitzgerald et al. 2014; Parasa et al. 2014) . Future use of our flow-cytometry-based assay will help determine which monocyte subsets are the targets of Mtb, probe pathogenic vs non-pathogenic mycobacteria infectivity, and compare mutant strains infectivity in in vitro granuloma models. Our assay can also be applied to studies where alterations in granuloma formation were observed. For instance, Guirado et al. found that, following Mtb infection, granuloma formation was altered in PBMCs from latently infected individuals, which exhibited accelerated cell recruitment and better control of bacillary load over time compared to PBMCs from naïve donors (Guirado et al. 2015) . Such studies could benefit from our assay to explore whether changes in infection of monocyte subsets supports the formation of altered granuloma structures.
